The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations
Open accessAbstract
Vascular and angiogenic processes provide an important target for novel cancer therapeutics. Dynamic contrast-enhanced magnetic resonance imaging is being used increasingly to noninvasively monitor the action of these therapeutics in early-stage clinical trials. This publication reports the outcome of a workshop that considered the methodology and design of magnetic resonance studies, recommending how this new tool might best be used.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
(2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,762
Tofts, P. S., Brix, G., Buckley, D. L., Evelhoch, J. L., Henderson, E., Knopp, M. V., Larsson, H. B. W., Lee, T.-Y., Mayr, N. A., Parker, G. J. M., et al. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199909)10:3<223::aid-jmri2>3.0.co;2-s · Cited by 3,143
Self-citationYang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging
Tofts, P. S. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070113 · Cited by 1,478
Self-citationCerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.
Aronen, H. J., Gazit, I. E., Louis, D. N., Buchbinder, B. R., Pardo, F. S., Weisskoff, R. M., Harsh, G. R., Cosgrove, G. R., Halpern, E. F., & Hochberg, F. H. (1994) · Radiology · doi:10.1148/radiology.191.1.8134596 · Cited by 908
Pharmacokinetic Parameters in CNS Gd-DTPA Enhanced MR Imaging
Brix, G., Semmler, W., Port, R., Schad, L. R., Layer, G., & Lorenz, W. J. (1991) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199107000-00018 · Cited by 659
Morgan, B., Thomas, A. L., Drevs, J., Hennig, J., Buchert, M., Jivan, A., Horsfield, M. A., Mross, K., Ball, H. A., Lee, L., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.092 · Cited by 652
Vascular Targeting Agents as Cancer Therapeutics
Thorpe, P. E. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0642-03 · Cited by 577
Dynamic contrast‐enhanced MRI in clinical oncology: Current status and future directions
Padhani, A. R. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10176 · Cited by 472
Self-citationPharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers.
Weinmann, H., Laniado, M., & Mutzel, W. (1984) · PubMed · Cited by 462
Larsson, H. B. W., Stubgaard, M., Frederiksen, J. L., Jensen, M., Henriksen, O., & Paulson, O. B. (1990) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910160111 · Cited by 431
Roberts, H. C., Roberts, T. P. L., Brasch, R. C., & Dillon, W. P. (2000) · PubMed Central · Cited by 427
Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model
Tofts, P. S., Berkowitz, B., & Schnall, M. D. (1995) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910330416 · Cited by 399
Self-citationKey factors in the acquisition of contrast kinetic data for oncology
Evelhoch, J. L. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199909)10:3<254::aid-jmri5>3.0.co;2-9 · Cited by 369
Self-citationVascular‐targeting therapies for treatment of malignant disease
Siemann, D. W., Chaplin, D. J., & Horsman, M. R. (2004) · Cancer · doi:10.1002/cncr.20299 · Cited by 310
Self-citationPharmacokinetic Mapping of the Breast: A New Method for Dynamic MR Mammography
Hoffmann, U., Brix, G., Knopp, M. V., Heβ, T., & Lorenz, W. J. (1995) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910330408 · Cited by 303
Self-citationJayson, G. C., Zweit, J., Jackson, A., Mulatero, C., Julyan, P., Ranson, M., Broughton, L., Wagstaff, J., Hakannson, L., Groenewegen, G., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1484 · Cited by 258
Self-citationPadhani, A. R., & Husband, J. E. (2001) · Clinical Radiology · doi:10.1053/crad.2001.0762 · Cited by 230
Self-citationMR imaging of tumor microcirculation: Promise for the new millenium
Taylor, J. S., Tofts, P. S., Port, R., Evelhoch, J. L., Knopp, M., Reddick, W. E., Runge, V. M., & Mayr, N. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199912)10:6<903::aid-jmri1>3.0.co;2-a · Cited by 223
Self-citationIssues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours
Howe, F. A., Robinson, S. P., McIntyre, D. J. O., Stubbs, M., & Griffiths, J. R. (2001) · NMR in Biomedicine · doi:10.1002/nbm.716 · Cited by 183
Self-citationImproved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors
Li, K.-L., Zhu, X. P., Waterton, J., & Jackson, A. (2000) · Journal of Magnetic Resonance Imaging · doi:10.1002/1522-2586(200008)12:2<347::aid-jmri19>3.0.co;2-7 · Cited by 180
Self-citationDynamic magnetic resonance imaging of tumor perfusion
Collins, D. J., & Padhani, A. R. (2004) · IEEE Engineering in Medicine and Biology Magazine · doi:10.1109/memb.2004.1360410 · Cited by 169
Self-citationPadhani, A. R., MacVicar, A. D., Gapinski, C. J., Dearnaley, D. P., Parker, G. J. M., John Suckling, A., Leach, M. O., & Husband, J. E. (2001) · Radiology · doi:10.1148/radiology.218.2.r01ja04365 · Cited by 155
Self-citationWorkman, P. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033455279 · Cited by 150
Self-citationCao, Y. (2004) · The biomedical & life sciences collection. · doi:10.1016/j.semcancer.2003.09.018 · Cited by 148
Measuring blood volume and vascular transfer constant from dynamic, T‐weighted contrast‐enhanced MRI
Johnson, G., Wetzel, S. G., Cha, S., Babb, J. S., & Tofts, P. S. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20049 · Cited by 145
Self-citationGalbraith, S. M., Rustin, G. J. S., Lodge, M. A., Taylor, N. J., Stirling, J., Jameson, M. B., Thompson, P. I., Hough, D., Gumbrell, L. A., & Padhani, A. R. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.144 · Cited by 144
Self-citationBhujwalla, Z. M., Artemov, D., Natarajan, K., Ackerstaff, E., & Solaiyappan, M. (2001) · Neoplasia · doi:10.1038/sj.neo.7900129 · Cited by 117
Turetschek, K., Preda, A., Novikov, V., Brasch, R. C., Weinmann, H. J., Wunderbaldinger, P., & Roberts, T. P. L. (2004) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20049 · Cited by 114
Parker, G. J. M., Barker, G. J., & Tofts, P. S. (2001) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1112 · Cited by 112
Self-citationTumor angiogenesis: Molecular pathology, therapeutic targeting, and imaging
Li, W. W. (2000) · Academic Radiology · doi:10.1016/s1076-6332(00)80629-7 · Cited by 111
Contrast agents in functional MR imaging
Sorensen, A. G., Tievsky, A. L., Østergaard, L., Weisskoff, R. M., & Rosen, B. R. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070108 · Cited by 108
Functional magnetic resonance imaging: A review of methodological aspects and clinical applications
Hennig, J., Speck, O., Koch, M. A., & Weiller, C. (2003) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10330 · Cited by 100
Molecular targeting of angiogenesis
Alessi, P., Ebbinghaus, C., & Neri, D. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2003.08.001 · Cited by 84
Translating basic cancer research into new cancer therapeutics
Workman, P., & Kaye, S. B. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02319-5 · Cited by 74
Self-citationChallenges of PK/PD measurements in modern drug development
Workman, P. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00395-7 · Cited by 65
Self-citationStructural, Functional, and Molecular MR Imaging of the Microvasculature
Neeman, M., & Dafni, H. (2003) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.5.040202.121606 · Cited by 62
Hackländer, T., Reichenbach, J. R., Hofer, M., & Mödder, U. (1996) · PubMed · Cited by 56
T 1 : The Longitudinal Relaxation Time
Gowland, P. A., & Stevenson, V. L. (2003) · Wiley eBooks · doi:10.1002/0470869526.ch5 · Cited by 52
A model of the dual effect of gadopentetate dimeglumine on dynamic brain MR images
Barbier, E., den Boer, J. A., Peters, A. R., Rozeboom, A. R., Sau, J., & Bonmartin, A. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199909)10:3<242::aid-jmri4>3.0.co;2-h · Cited by 51
Hackländer, T., Reichenbach, J. R., & Mödder, U. (1997) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199711000-00003 · Cited by 48
Parker, G. J. M., Baustert, I. C., Tanner, S. F., & Leach, M. O. (2000) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(99)00124-1 · Cited by 46
Self-citationMeasurement of spin-lattice relaxation times with FLASH for dynamic MRI of the breast
Brookes, J. A. S., Redpath, T. W., Gilbert, F. J., Needham, G., & Murray, A. D. (1996) · British Journal of Radiology · doi:10.1259/0007-1285-69-819-206 · Cited by 45
Tofts, P. S., Steens, S. C. A., & van Buchem, M. A. (2003) · Wiley eBooks · doi:10.1002/0470869526.ch8 · Cited by 40
Self-citationT 1 ‐W DCE‐MRI: T 1 ‐Weighted Dynamic Contrast‐Enhanced MRI
Parker, G. J. M., & Padhani, A. R. (2003) · Wiley eBooks · doi:10.1002/0470869526.ch10 · Cited by 36
Self-citationWheeler‐Kingshott, C. A. M. G., Barker, G. J., Steens, S. C. A., & van Buchem, M. A. (2003) · Wiley eBooks · doi:10.1002/0470869526.ch7 · Cited by 28
Molecular therapeutics: promise and challenges
Kohn, E. C., Lu, Y., Wang, H., Yu, Q., Yu, S., Hall, H. S., Smith, D. L., Meric‐Bernstam, F., Hortobágyi, G. N., & Mills, G. B. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.01.009 · Cited by 24
Histograms: Measuring Subtle Diffuse Disease
Tofts, P. S., Davies, G. R., & Dehmeshki, J. (2003) · Wiley eBooks · doi:10.1002/0470869526.ch18 · Cited by 22
Self-citationNewell, D. R., Searle, K. M., Westwood, N., & Burtles, S. S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601106 · Cited by 15
Cited by
Imaging biomarker roadmap for cancer studies
O'Connor, J. P. B., Aboagye, E. O., Adams, J. E., Aerts, H. J. W. L., Barrington, S. F., Beer, A. J., Boellaard, R., Bohndiek, S. E., Brady, M., Brown, G., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.162 · Cited by 1,091
Self-citationAnti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
Keunen, O., Johansson, M., Oudin, A., Sanzey, M., Rahim, S. A. A., Fack, F., Thorsen, F., Taxt, T., Bartos, M., Jirik, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014480108 · Cited by 606
Kuhl, C., Weigel, S., Schrading, S., Arand, B., Bieling, H., König, R., Tombach, B., Leutner, C., Rieber-Brambs, A., Nordhoff, D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.0839 · Cited by 501
Improving tumour heterogeneity MRI assessment with histograms
Just, N. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.512 · Cited by 497
DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
O'Connor, J. P. B., Jackson, A., Parker, G. J. M., & Jayson, G. C. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603515 · Cited by 484
Self-citation
Metadata
- Authors
- Leach, M. O., Brindle, K. M., Evelhoch, J. L., Griffiths, J. R., Horsman, M. R., Jackson, A., Jayson, G. C., Judson, I. R., Knopp, M. V., Maxwell, R. J., McIntyre, D., Padhani, A. R., Price, P., Rathbone, R., Rustin, G. J., Tofts, P. S., Tozer, G. M., Vennart, W., Waterton, J. C., Williams, S. R., & Workman, P.
- Venue
- British Journal of Cancer
- Published
- 2005-05
- Volume
- 92
- Issue
- 9
- Pages
- 1599-1610
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2150374672
- Cited by
- 513
- References
- 49
- FWCI
- 26.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.